Masimo Corp (FRA:3M4)
€ 120.8 -0.9 (-0.74%) Market Cap: 6.52 Bil Enterprise Value: 7.27 Bil PE Ratio: 89.29 PB Ratio: 5.10 GF Score: 88/100

Masimo Corp at JPMorgan Healthcare Conference Transcript

Jan 11, 2023 / 06:30PM GMT
Release Date Price: €146.35 (+2.85%)
Lilia;Celine Breton Lozada
JPMorgan Chase & Co, Research Division - Research Analyst

Hi, everyone. I'm Lilia Lozada. I'm on the med tech team here at JPMorgan, and I'm happy to have the Masimo management team with us here today. I'll pass things over to CFO, Micah Young, before we open things up for Q&A.

Micah Young
Masimo Corporation - Executive VP of Finance & CFO

Thank you. Thank you, Lily. All right. I appreciate the opportunity to be here with you today. Thank you to the JPMorgan team for hosting us. Before I get started, I'm just going to go through some housekeeping here.

This presentation will include forward-looking statements that involve risks and uncertainties as well as non-GAAP financial measures, which -- you can refer to those in our SEC filings as well as on our Investor Relations website.

All right. So I'm going to start out with just a brief overview. For those who are not familiar with the Masimo story. We are a global leader -- global market leader in pulse oximetry as well as other highly

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot